Sublethal injury and resuscitation of Candida albicans after amphotericin B treatment

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 4, 2003, Pages 1200-1206

  Liao, Robert S ^a   Rennie, Robert P ^a,b,c   Talbot, James A ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; KETOCONAZOLE; MICONAZOLE;

ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CELL DEATH; CELL POPULATION; COLONY FORMATION; COLONY FORMING UNIT; DRUG EFFECT; GROWTH INHIBITION; INJURY; LETHALITY; METABOLIC ACTIVATION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; RESUSCITATION;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; DOSE-RESPONSE RELATIONSHIP, DRUG;

EID: 0037378737     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.4.1200-1206.2003     Document Type: Article

References (37)

1. Amsterdam, D. 1996. Susceptibility testing of antimicrobials in liquid media, p. 52-111. In V. Lorian (ed.), Antibiotics in laboratory medicine, 4th ed. The Williams & Wilkins Co., Baltimore, Md.
2. Bashford, C. L., B. Chance, J. C. Smith, and T. Yashida. 1979. The behavior of oxonol dyes in phospholipid dispersion. Biophys. J. 25:63-85.
3. Beck-Sagué C. M., W. R. Jarvis, and the National Nosocomial Infections Surveillance System. 1993. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. J. Infect. Dis. 167:1247-1251.
4. Beggs, W. H. 1984. Growth phase in relation to ketoconazole and miconazole susceptibilities of Candida albicans. Antimicrob. Agents Chemother. 25:316-318.
5. Beggs, W. H. 1994. Physiochemical cell damage in relation to lethal amphotericin B action. Antimicrob. Agents Chemother. 38:363-364.
6. Bennett, J. 1990. Antifungal agents, p. 404-406. In G. L. Mandell, R. G. Douglas, and J. E. Bennett (ed.), Principles and practice of infectious diseases, 3rd ed. Churchill Livingstone, New York, N.Y.
7. Beuchat, L. R. 1984. Injury and repair of yeasts and moulds. Soc. Appl. Bacteriol. Symp. Set. 12:293-306.
8. Bodey, G. P. 1996. Antifungal agents, p. 229-248. In V. T. Andriole (ed.), Current infectious disease drugs. Current Medicine, Philadelphia, Pa.
9. Busta, F. F. 1978. Introduction to injury and repair of microbial cells. Adv. Appl. Microbiol. 23:195-201.
10. Centers for Disease Control and Prevention. 1996. National nosocomial infections surveillance (NNIS) report, data summary from October 1986-April 1996. Am. J. Infect. Control 24:380-388.
11. Craig, W. A., and S. Gudmundsson. 1996. The postantibiotic effect, p. 296-329. In V. Lorian (ed.), Antibiotics in laboratory medicine, 4th ed. The Williams & Wilkins Co., Baltimore, Md.
12. De Nollin, S., H. Van Belle, G. Goossens, F. Thone, and M. Borgers. 1977. Cytochemical and biochemical studies of yeasts after in vitro exposure to miconazole. Antimicrob. Agents Chemother. 11:500-513.
13. De Nollin, S., and M. Borgers. 1975. The effects of miconazole on the ultrastructure of Candida albicans. Sabouraudia 13:63-73.
14. Edwards, J. E., et al. 1997. International Conference for the Development of a Consensus on the Management and Prevention of Severe Candida Infections. Clin. Infect. Dis. 25:43-59.
15. Ernst, E. J., M. E. Klepser, and M. A. Pfaller. 2000. Postantifungal effects of echinocandin, azole, and polyene antifungal agents against Candida albicans and Cryptococcus neoformans. Antimicrob. Agents Chemother. 44:1108-1111.
16. Garcia, M. T., M. T. Llorente, F. Minguez, and J. Prieto. 2000. Influence of temperature and concentration on the postantifungal effect and the effects of sub-MIC concentrations of four antifungal agents on previously treated Candida species. Chemotherapy (Basel) 46:245-252.
17. Haugland, R. P. 1992. Handbook of fluorescent probes and research chemicals, 5th ed. Molecular Probes, Inc., Eugene, Oreg.
18. Jawetz, E., G. F. Brooks, J. L. Melnick, J. S. Butel, E. A. Adelberg, and L. N. Ornston. 1995. The growth, survival & death of microorganisms, p. 44-52. In Medical microbiology, 20th ed. Appleton & Lange, Norwalk, Conn.
19. Jones, R. P. 1987. Measures of yeast death and deactivation and their meaning, parts I and II. Process. Biochem. 22:118-134.
20. Katsui, N., T. Tsuchido, M. Takano, and I. Shibasaki. 1982. Viability of heat-stressed cells of micro-organisms as influenced by pre-incubation and post-incubation temperatures. J. Appl. Bacteriol. 53:103-108.
21. Lentini, A. 1993. A review of the various methods available for monitoring the physiological status of yeast: yeast viability and vitality. Fermentation 6:321-327.
22. Liao, R. S., R. P. Rennie, and J. A. Talbot. 1999. Assessment of the effect of amphotericin B on the vitality of Candida albicans. Antimicrob. Agents Chemother. 43:1034-1041.
23. Mason, C. A., G. Hamer, and J. D. Bryers. 1986. The death and lysis of microorganisms in environmental processes. FEMS Microbiol. Rev. 39:373-401.
24. McGinnis, M. R., and M. G. Rinaldi. 1996. Antifungal drugs: mechanisms of action, drug resistance, susceptibility testing, and assays of activity in biologic fluids, p. 176-211. In V. Lorian (ed.), Antibiotics in laboratory medicine, 4th ed. The Williams & Wilkins Co., Baltimore, Md.
25. a. National Committee for Clinical Laboratory Standards. 1997. Reference method for broth dilution antifungal susceptibility testing of yeasts. M27-A. National Committee for Clinical Laboratory Standards, Wayne, Pa.
26. Odds, F. C., A. Cockayne, J. Hayward, and A. B. Abbott. 1985. Effects of imidazole- and triazole-derivative antifungal compounds on the growth and morphological development of Candida albicans hyphae. J. Gen. Microbiol. 131(Pt. 10):2581-2589.
27. Portillo, F., and C. Gancedo. 1984. Mode of action of miconazole on yeasts: inhibition of the mitochondrial ATPase. Eur. J. Biochem. 143:273-276.
28. Postgate, J. R. 1976. Death in macrobes and microbes, p. 1-18. In T. R. G. Gray and J. R. Postgate (ed.), The survival of vegetative microbes. Cambridge University Press, Cambridge, United Kingdom.
29. Rex, J. H., M. A. Pfaller, T. J. Walsh, V. Chaturvedi, A. Espinel-Ingroff, M. A. Ghannoum, L. L. Gosey, F. C. Odds, M. G. Rinaldi, D. J. Sheehan, and D. W. Warnock. 2001. Antifungal susceptibility testing: practical aspects and current challenges. Clin. Microbiol. Rev. 14:643-658.
30. Schiven, M., C. Scheven, K. Hahn, and A. Senf. 1995. Post-antibiotic effect and post-expositional polyene antagonism of azole antifungal agents in Candida albicans dependence on substance lipophilia. Mycoses 38:435-442.
31. Shu, M., A. N. B. Ellepola, and L. P. Samaranayake. 2001. Effects of two different growth media on the postantifungal effect induced by polyenes on Candida species. J. Clin. Microbiol. 39:2732-2735.
32. Slater, T. F., B. Sawyer, and U. Straul. 1963. Studies on succinate-tetrazolium reductase systems. Biochim. Biophys. Acta 77:383-393.
33. Sud, I. J., and D. S. Feingold. 1981. Heterogeneity of action mechanisms among antimycotic imidazoles. Antimicrob. Agents Chemother. 20:71-74.
34. Tellier, R., M. Krajden, G. A. Grigoriew, and I. Campbell. 1992. Innovative endpoint determination system for antifungal susceptibility testing of yeasts. Antimicrob. Agents Chemother. 36:1619-1625.
35. Turnidge, J. D., S. Gudmundsson, B. Vogelman, and W. A. Craig. 1994. The postantibiotic effect of antifungal agents against common pathogenic yeasts. J. Antimicrob. Chemother. 34:83-92.
36. Van den Bossche, H., J. M. Ruysschaert, F. Defrise-Quertain, G. Willemsens, F. Cornelissen, P. Marichal, W. Cools, and J. Van Cutsem. 1982. The interaction of miconazole and ketoconazole with lipids. Biochem. Pharmacol. 31:2609-2617.
37. Wey, S. B., M. Mori, M. A. Pfaller, R. F. Woolson, and R. P. Wenzel. 1988. Hospital-acquired candidemia. The attributable mortality and excess length of stay. Arch. Intern. Med. 148:2642-2645.